Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MDM2 | Q00987 | 6/20 | 0.51 |
| ▸ | TLR2 | O60603 | 2/20 | 0.49 |
| ▸ | MDM4 | O15151 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | CASP3 | P42574 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | TNF | P01375 | 3/20 | 0.46 |
| ▸ | CASP1 | P29466 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25358998 | 1.00 | MDM2 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL31398346 | 1.00 | MDM2 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL31689003 | 0.97 | MDM2 (0.50) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL178741 | 0.94 | MDM4 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL29376536 | 0.94 | MDM4 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL119481 | 0.94 | MDM4 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL29407853 | 0.94 | MDM4 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL30055069 | 0.94 | MDM4 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL17633370 | 0.89 | MDM2 (0.51) | MDM2TLR2MDM4TP53CASP3 | |
| SCHEMBL29624261 | 0.88 | SLC17A5 (0.49) | MDM2TLR2MDM4TP53CASP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025070731-A1 | PEPTIDEPEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |
| WO-2025070720-A1 | PEPTIDE | ペプチドリーム株式会社 | 2025-04-03 | — | — | WO | disclosed |